Note: A pharmicist friend is heavy into AKRX (Akorn, Inc.) @ $2... he's expecting $20 over the longer haul because they recently purchased a major competitor in the generic drug sector. He expects big things in 2012...fwiw..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.